Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (321-330 of 594) with videos related to

Pageof 60
Sort By:
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Oncogene|November 22, 2002
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classificationAdel K El-Naggar, Hyung W Kim, Gary L Clayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionMichelle A T Hildebrandt, Scott M Lippman, Carol J Etzel, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancyHidetoshi Kawaguchi, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosisHumam Kadara, Carmen Behrens, Ping Yuan, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Pageof 60

Showing results (321-330 of 594) with videos related to

Sort By:
Pageof 60
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.
Oncogene|November 22, 2002
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classificationAdel K El-Naggar, Hyung W Kim, Gary L Clayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionMichelle A T Hildebrandt, Scott M Lippman, Carol J Etzel, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancyHidetoshi Kawaguchi, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosisHumam Kadara, Carmen Behrens, Ping Yuan, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Pageof 60